title: The value of routine monitoring of mycophenolic acid plasma levels after clinical heart transplantation.
authors.affiliation: Department of Internal Medicine and Thorax Center, Erasmus University, and University Hospital Rotterdam-Dijkzigt, Rotterdam, The Netherlands.
authors.forename: C J
authors.initials: CJ
authors.lastname: Hesse
authors.forename: P
authors.initials: P
authors.lastname: Vantrimpont
authors.forename: I C
authors.initials: IC
authors.lastname: van Riemsdijk-van Overbeeke
authors.forename: T
authors.initials: T
authors.lastname: van Gelder
authors.forename: A H
authors.initials: AH
authors.lastname: Balk
authors.forename: W
authors.initials: W
authors.lastname: Weimar
mesh_terms: D000208:Acute Disease; D001706:Biopsy; D016572:Cyclosporine / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D016903:Drug Monitoring; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000097:blood; D016027:Heart Transplantation / Q000276:immunology / Q000473:pathology / Q000502:physiology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000493:pharmacokinetics* / Q000627:therapeutic use; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000097:blood* / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D016559:Tacrolimus / Q000627:therapeutic use; D013997:Time Factors
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine; D009173:Mycophenolic Acid; D016559:Tacrolimus